Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.21.2
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 13,376,141 9,466,782
Stock options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 6,415,030 5,608,057
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 1,970,955 1,713,083
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 4,990,156 2,145,642